Preoperative evaluation of pelvic masses with combined 18F-fluorodeoxyglucose positron emission tomography and computed tomography

International Journal of Gynecology and Obstetrics

Volumn 102, Issue 2, 2008, Pages 124-127

  Yamamoto, Yorito ^a   Oguri, Hiroyoshi ^a   Yamada, Ruriko ^a   Maeda, Nagamasa ^a   Kohsaki, Shino ^a   Fukaya, Takao ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Borderline malignant tumor; FDG PET CT; Ovarian cancer; Pelvic mass

Indexed keywords

TUMOR MARKER;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOGRAPHY; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS TUMOR; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; STATISTICAL SIGNIFICANCE;

EID: 46749084233     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2008.02.019     Document Type: Article

References (25)

1. Gillis C.R., Hole D.J., Still R.M., Davis J., and Kaye S.B. Medical audit, cancer registration, and survival in ovarian cancer. Lancet 337 (1991) 611-612
2. Finkler N.J., Benacerraf B., Lavin P.T., Wojciechowski C., and Knapp R.C. Comparison of serum CA 125, clinical impression, and ultrasound in the preoperative evaluation of ovarian masses. Obstet Gynecol 72 (1988) 659-664
3. Vasilev S.A., Schlaerth J.B., Campeau J., and Morrow C.P. Serum CA 125 levels in preoperative evaluation of pelvic masses. Obstet Gynecol 71 (1988) 751-756
4. Eisenkop S.M., Spirtos N.M., Montag T.W., Nalick R.H., and Wang H. The impact of subspecialty on the management of advanced ovarian cancer. Gynecol Oncol 47 (1992) 203-209
5. Kehoe S., Powell J., Wilson S., and Woodman C. The influence of the operating surgeon's specialisation on patient survival in ovarian carcinoma. Br J Cancer 70 (1994) 1014-1017
6. Horowitz N.S., Dehdashti F., Herzog T.J., Rader J.S., Powell M.A., Gibb R.K., et al. Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. Gynecol Oncol 95 3 (2004) 546-551
7. Choi H.J., Roh J.W., Seo S.S., Lee S., Kim J.Y., Kim S.K., et al. Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study. Cancer 106 4 (2006) 914-922
8. Loft A., Berthelsen A.K., Roed H., Ottosen C., Lundvall L., Knudsen J., et al. The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study. Gynecol Oncol 106 1 (2007) 29-34
9. Simcock B., Neesham D., Quinn M., Drummond E., Milner A., and Hicks R.J. The impact of PET/CT in the management of recurrent ovarian cancer. Gynecol Oncol 103 1 (2006) 271-276
10. Thrall M.M., DeLoia J.A., Gallion H., and Avril N. Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer. Gynecol Oncol 105 1 (2007) 17-22
11. Risum S., Hogdall C., Loft A., Berthelsen A.K., Hogdall E., Nedergaard L., et al. The diagnostic value of PET/CT for primary ovarian cancer-a prospective study. Gynecol Oncol 105 1 (2007) 145-149
12. Castellucci P., Perrone A.M., Picchio M., Ghi T., Farsad M., Nanni C., et al. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology. Nucl Med Commun 28 8 (2007) 589-595
13. Staging announcement. FIGO Cancer Committee. Gynecol Oncol 25 (1986) 383-385
14. Jacobs I., Oram D., Fairbanks J., Turner J., Frost C., and Grudzinskas J.G. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynecol 97 (1990) 922-929
15. Grab D., Flock F., Stöhr I., Nüssle K., Rieber A., Fenchel S., et al. Classification of asymptomatic adnexal masses by ultrasound, magnetic resonance imaging, and positron emission tomography. Gynecol Oncol 77 (2000) 454-459
16. Kumar R., and Alavi A. PET imaging in gynecologic malignancies. Radiol Clin North Am 44 (2004) 1155-1167
17. Liu J., Xu Y., and Wang J. Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis of ovarian carcinoma. Euro J Radiol (2007) 328-334
18. Rieber A., Nussle K., Stohr I., Grab D., Fenchel S., Kreienberg R., et al. Preoperative diagnosis of ovarian tumors with MR imaging: comparison with transvaginal sonography, positron emission tomography, and histologic findings. AJR Am J Roentgenol 177 1 (2001) 123-129
19. Yoshida Y., Kurokawa T., Kawahara K., Tsuchida T., Okazawa H., Fujibayashi Y., et al. Incremental benefits of FDG positron emission tomography over CT alone for the preoperative staging of ovarian cancer. AJR Am J Roentgenol 182 1 (2004) 227-233
20. 18F]FDG). Gynecol Oncol 51 (1993) 197-204
21. Rice L.W., Berkowitz R.S., Mark S.D., Yavner D.L., and Lage J.M. Epithelial ovarian tumors of borderline malignancy. Gynecol Oncol 39 (1990) 195-198
22. Manchul L.A., Simm J., Levin W., Fyles A.W., Dembo A.J., Pringle J.F., et al. Borderline epithelial ovarian tumors: a review of 81 cases with an assessment of the impact of treatment. Int J Radiat Oncol Biol Phys 22 5 (1992) 867-874
23. Gershenson D.M., and Silva E.G. Serous ovarian tumors of low malignant potential with peritoneal implants. Cancer 65 3 (1990) 578-585
24. Van Vierzen P.B., Massuger L.F., Ruys S.H., and Barentsz J.O. Borderline ovarian malignancy: ultrasound and fast dynamic MR findings. Eur J Radiol 28 (1998) 136-142
25. Chura J.C., Truskinovsky A.M., Judson P.L., Johnson L., Geller M.A., and Downs Jr. L.S. Positron emission tomography and leiomyomas: clinicopathologic analysis of 3 cases of PET scan-positive leiomyomas and literature review. Gynecol Oncol 104 1 (2007) 247-252